BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3540015)

  • 1. Antineuron specific enolase staining reactions in sarcomas and carcinomas: its lack of neuroendocrine specificity.
    Leader M; Collins M; Patel J; Henry K
    J Clin Pathol; 1986 Nov; 39(11):1186-92. PubMed ID: 3540015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical localization of neuron specific enolase in small cell carcinomas and carcinoid tumours of the lung.
    Sheppard MN; Corrin B; Bennett MH; Marangos PJ; Bloom SR; Polak JM
    Histopathology; 1984 Mar; 8(2):171-81. PubMed ID: 6202617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical markers of small cell carcinoma and related neuroendocrine tumours of the lung.
    Addis BJ; Hamid Q; Ibrahim NB; Fahey M; Bloom SR; Polak JM
    J Pathol; 1987 Oct; 153(2):137-50. PubMed ID: 2826741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-alpha 1-antichymotrypsin staining of 194 sarcomas, 38 carcinomas, and 17 malignant melanomas. Its lack of specificity as a tumour marker.
    Leader M; Patel J; Collins M; Henry K
    Am J Surg Pathol; 1987 Feb; 11(2):133-9. PubMed ID: 2433954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical demonstration of neuron-specific enolase (NSE) in human lung cancers.
    Bergh J; Esscher T; Steinholtz L; Nilsson K; Påhlman S
    Am J Clin Pathol; 1985 Jul; 84(1):1-7. PubMed ID: 2409790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of the sensitivity and specificity of the cytokeratin marker CAM 5.2 for epithelial tumours. Results of a study of 203 sarcomas, 50 carcinomas and 28 malignant melanomas.
    Leader M; Patel J; Makin C; Henry K
    Histopathology; 1986 Dec; 10(12):1315-24. PubMed ID: 2434403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A monoclonal antibody against neuron-specific enolase. Immunohistochemical comparison with a polyclonal antiserum.
    Thomas P; Battifora H; Manderino GL; Patrick J
    Am J Clin Pathol; 1987 Aug; 88(2):146-52. PubMed ID: 3618548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staining for factor VIII related antigen and Ulex europaeus agglutinin I (UEA-I) in 230 tumours. An assessment of their specificity for angiosarcoma and Kaposi's sarcoma.
    Leader M; Collins M; Patel J; Henry K
    Histopathology; 1986 Nov; 10(11):1153-62. PubMed ID: 3100411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mac387: its non-specificity as a tumour marker or marker of histiocytes.
    Loftus B; Loh LC; Curran B; Henry K; Leader M
    Histopathology; 1991 Sep; 19(3):251-5. PubMed ID: 1916699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esthesioneuroblastoma. Intermediate filaments, neuroendocrine, and tissue-specific antigens.
    Axe S; Kuhajda FP
    Am J Clin Pathol; 1987 Aug; 88(2):139-45. PubMed ID: 3039834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibody HISL-19 as an immunocytochemical probe for neuroendocrine differentiation. Its application in diagnostic pathology.
    Krisch K; Buxbaum P; Horvat G; Krisch I; Neuhold N; Ulrich W; Srikanta S
    Am J Pathol; 1986 Apr; 123(1):100-8. PubMed ID: 3515956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal islet antibody HISL-19 as a tool in the diagnosis of neuroendocrine carcinomas of the skin.
    Buxbaum P; Horvat G; Gamper C; Krisch K
    Cancer Detect Prev Suppl; 1987; 1():263-8. PubMed ID: 3155378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoperoxidase staining for Ia-like antigens in paraffin-embedded tissues from human melanoma and lung carcinoma.
    Wilson BS; Herzig MA; Lloyd RV
    Am J Pathol; 1984 Apr; 115(1):102-8. PubMed ID: 6369992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroendocrine differentiation in prostatic carcinomas. A retrospective autopsy study.
    Turbat-Herrera EA; Herrera GA; Gore I; Lott RL; Grizzle WE; Bonnin JM
    Arch Pathol Lab Med; 1988 Nov; 112(11):1100-5. PubMed ID: 2460064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuron-specific enolase in neuroendocrine tumors of the thymus, bronchus, and skin.
    Wick MR; Scheithauer BW; Kovacs K
    Am J Clin Pathol; 1983 Jun; 79(6):703-7. PubMed ID: 6303108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical characterization of a set of monoclonal antibodies to human neuron-specific enolase.
    Seshi B; True L; Carter D; Rosai J
    Am J Pathol; 1988 May; 131(2):258-69. PubMed ID: 3282444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuron-specific enolase in mucosal endocrine cells and carcinoid tumours of the small intestine: a comparative study with neuron-specific enolase immunocytochemistry and silver stains.
    Lundqvist M; Wilander E; Esscher T; Påhlman S
    Histochem J; 1985 Mar; 17(3):323-31. PubMed ID: 2411685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum neurone-specific enolase levels in patients with neuroendocrine and carcinoid tumours.
    Cunningham RT; Johnston CF; Irvine GB; Buchanan KD
    Clin Chim Acta; 1992 Nov; 212(3):123-31. PubMed ID: 1477975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subepithelial neuroendocrine cells and carcinoid tumours of the human small intestine and appendix. A comparative immunohistochemical study with regard to serotonin, neuron-specific enolase and S-100 protein reactivity.
    Lundqvist M; Wilander E
    J Pathol; 1986 Feb; 148(2):141-7. PubMed ID: 3512805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical demonstration of neurone specific enolase in bone marrow infiltrated by neuroblastoma.
    Caillaud JM; Martinez-Madrigal F; Hartmann O; Carlu C
    J Clin Pathol; 1991 Apr; 44(4):309-12. PubMed ID: 2030150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.